Index of /wp-content/uploads/2023/02

[ICO]NameLast modifiedSizeDescription
[PARENTDIR]Parent Directory  -  
[IMG]cropped-logo-150x59.png2023-11-28 12:40 2.8K 
[IMG]logo-150x59.png2023-02-27 13:00 2.8K 
[IMG]2.-prijava-nezeljenog-dejstva-lijeka-slika-portal-150x150.jpg2023-02-03 10:37 3.4K 
[IMG]rezerva-150x150.jpg2023-02-03 10:38 3.6K 
[IMG]2.-prijava-nezeljenog-dejstva-lijeka-slika-portal-300x125.jpg2023-02-03 10:37 5.1K 
[IMG]7.-lista-ljekova-pod-dodatnim-pracenjem-slika-portal-150x150.jpg2023-02-03 10:38 5.6K 
[IMG]Slika-1-150x150.jpg2023-02-04 14:28 5.7K 
[IMG]rezerva-300x169.jpg2023-02-03 10:38 6.1K 
[IMG]Slika-3-150x150.jpg2023-02-04 14:28 6.7K 
[IMG]Slika-2-150x150.jpg2023-02-04 14:28 6.8K 
[IMG]6.-lista-ozbiljnih-nezeljenih-dejstava-slika-portal-150x150.jpg2023-02-03 10:38 7.0K 
[IMG]3.-uputstva-za-nosioca-dozvole-za-lijek-slika-portal-150x150.jpg2023-02-03 10:37 7.0K 
[IMG]cropped-logo-300x37.png2023-11-28 12:40 9.1K 
[IMG]logo-300x37.png2023-02-27 13:00 9.1K 
[IMG]cropped-logo.png2023-11-28 12:40 9.2K 
[IMG]7.-lista-ljekova-pod-dodatnim-pracenjem-slika-portal-300x200.jpg2023-02-03 10:38 9.9K 
[IMG]Slika-2-300x172.jpg2023-02-04 14:28 11K 
[IMG]logo.png2023-02-27 13:00 12K 
[IMG]Slika-1-300x250.jpg2023-02-04 14:28 13K 
[ ]Instruction-on-the-manner-of-submitting-ADR-report.pdf2023-02-03 12:14 14K 
[IMG]3.-uputstva-za-nosioca-dozvole-za-lijek-slika-portal-300x199.jpg2023-02-03 10:37 14K 
[IMG]Slika-3-235x300.jpg2023-02-04 14:28 14K 
[ ]Instruction-on-the-manner-of-sending-letters-to-health-professionals.pdf2023-02-03 12:14 14K 
[IMG]6.-lista-ozbiljnih-nezeljenih-dejstava-slika-portal-300x200.jpg2023-02-03 10:38 14K 
[IMG]4.-pisma-zdravstvenim-radnicima-finalna-slika-150x150.png2023-02-08 12:16 16K 
[ ]Registar_veledrogerija_14_02_2023.xlsx2023-02-14 09:55 17K 
[ ]Obrazac-Utvrdjivanje-maksimalne-cijene-lijeka-na-veliko.docx2023-02-21 23:02 17K 
[IMG]3.uputstva-za-nosioca-dozvole-za-lijek-finalna-slika-150x150.png2023-02-08 12:16 20K 
[IMG]humani-ljekovi-300x73.png2023-02-24 12:16 21K 
[IMG]rezerva-768x432.jpg2023-02-03 10:38 21K 
[ ]4-Obavjestenje-stavljanje-lijeka-u-promet.docx2023-02-20 12:46 22K 
[ ]Obavjestenje-stavljanje-lijeka-u-promet.docx2023-02-20 14:47 22K 
[ ]Registar_veledrogerija_24_02_2023-1.xlsx2023-02-24 14:32 22K 
[ ]Registar_veledrogerija_24_02_2023-2.xlsx2023-02-24 14:32 22K 
[ ]Registar_veledrogerija_24_02_2023-3.xlsx2023-02-24 14:33 22K 
[ ]Registar_veledrogerija_24_02_2023.xlsx2023-02-24 14:20 24K 
[ ]documentation-required-for-issuing-expert-opinion-on-the-exemption-from-approved-packaging.pdf2023-02-10 13:11 24K 
[IMG]humani-ljekovi-150x150.png2023-02-24 12:16 25K 
[IMG]4.-pisma-zdravstvenim-radnicima-finalna-slika-300x133.png2023-02-08 12:16 26K 
[IMG]2.-prijava-nezeljenog-dejstva-lijeka-slika-portal.jpg2023-02-03 10:37 26K 
[ ]Instruction-on-the-manner-of-submitting-the-summary-of-PSMF.pdf2023-02-03 12:12 27K 
[ ]Documentation-required-for-Notification-of-a-Non-interventional-Study.pdf2023-02-24 11:51 27K 
[ ]Bortezomib-Pliva-Grafikon-sheme-lijecenja-v.2.pdf2023-02-17 07:33 32K 
[IMG]rezerva-1024x576.jpg2023-02-03 10:38 33K 
[IMG]rezerva.jpg2023-02-03 10:38 35K 
[IMG]5.-mjere-minimizacije-rizika-slika-portal-150x150.png2023-02-03 10:37 36K 
[IMG]1.-opste-informacije-slika-portal-150x150.png2023-02-03 10:37 37K 
[IMG]4.-pisma-zdravstvenim-radnicima-slika-portal-150x150.png2023-02-03 10:37 39K 
[IMG]8.-godisnji-izvjestaji-slika-portal-150x150.png2023-02-03 10:38 39K 
[IMG]1.opste-informacije-finalna-slika-150x150.png2023-02-08 12:16 39K 
[ ]Registar_veleprodaja.xlsx2023-02-10 07:56 40K 
[ ]Eliquis-Kartica-za-pacijenta.pdf2023-02-23 12:59 41K 
[IMG]3.uputstva-za-nosioca-dozvole-za-lijek-finalna-slika-300x156.png2023-02-08 12:16 42K 
[IMG]6.-lista-ozbiljnih-nezeljenih-dejstava-finalna-slika-150x150.png2023-02-08 12:16 43K 
[IMG]4.-pisma-zdravstvenim-radnicima-finalna-slika.png2023-02-08 12:16 43K 
[IMG]7.-lista-ljekova-pod-dodatnim-pracenjem-slika-portal-768x512.jpg2023-02-03 10:38 44K 
[IMG]Slika-2-768x440.jpg2023-02-04 14:28 44K 
[ ]Obrazac_za_SmPC_0902023-1.docx2023-02-17 08:42 44K 
[ ]Obrazac_za_SmPC_0902023.docx2023-02-13 12:45 44K 
[ ]Zahtjev-za-obnovu-dozvole-za-lijek_hum_05.2020.docx2023-02-20 12:17 44K 
[ ]Instruction-on-the-manner-of-submitting-RMP-19.01.2023..pdf2023-02-03 12:15 46K 
[ ]Bortezomib-Pliva-Brosura-sa-uputstvima-o-pripremi-doziranju-i-primjeni-v.2.pdf2023-02-17 07:33 46K 
[ ]Documentation-required-for-import-of-medicines-used-in-Clinical-Trial.pdf2023-02-24 11:52 46K 
[IMG]Slika-1-768x641.jpg2023-02-04 14:28 47K 
[ ]Opel-Astra-PG-CG-H61-06.02.-12.02.2023..pdf2023-02-13 13:20 50K 
[ ]Opel-Astra-PG-CG-H61-20.02.-26.02.2023..pdf2023-02-28 12:21 50K 
[ ]Opel-Astra-PG-CG-H61-13.02.-19.02.23..pdf2023-02-20 15:38 51K 
[ ]Opel-Insignia-PG-CG-H60-20.02.-26.02.2023..pdf2023-02-28 12:21 51K 
[ ]Opel-Insignia-30.01.-05.02.23..pdf2023-02-08 14:07 51K 
[ ]Opel-Insignia-PG-CG-H60-06.02.-12.02.2023..pdf2023-02-13 13:20 52K 
[IMG]6.-lista-ozbiljnih-nezeljenih-dejstava-slika-portal-768x512.jpg2023-02-03 10:38 52K 
[ ]Opel-Astra-30.01.-05.02.23..pdf2023-02-08 14:07 53K 
[ ]Obrazac_za_PIL_09022023-1.docx2023-02-17 08:42 54K 
[ ]Obrazac_za_PIL_09022023.docx2023-02-13 12:45 54K 
[IMG]3.-uputstva-za-nosioca-dozvole-za-lijek-slika-portal-768x509.jpg2023-02-03 10:37 55K 
[ ]Hemlibra-Vodic-za-laboratorijske-zdravstvene-radnike-v.2.pdf2023-02-23 14:44 55K 
[ ]Opel-Insignia-PG-CG-H60-13.02.-19.02.23..pdf2023-02-20 15:38 57K 
[ ]6-Zahtjev-za-prestanak-vazenja-dozvole-za-stavljanje-lijeka-u-promet-17.02.2023..docx2023-02-20 12:46 58K 
[ ]Zahtjev-za-prestanak-vazenja-dozvole-za-stavljanje-lijeka-u-promet-17.02.2023..docx2023-02-20 14:47 58K 
[ ]5-Zahtjev-za-prenos-dozvole-na-novog-nosioca-dozvole-17.02.2023..docx2023-02-20 12:46 61K 
[ ]Zahtjev-za-prenos-dozvole-na-novog-nosioca-dozvole-17.02.2023..docx2023-02-20 14:47 61K 
[ ]Hemlibra-Vodic-za-pacijente-i-njegovatelje-v.2.pdf2023-02-23 14:45 63K 
[IMG]Slika-2-1024x587.jpg2023-02-04 14:28 66K 
[ ]Zahtjev-za-odobrenje-prijavu-izmjena-i-dopuna-klinickog-ispitivanja.docx2023-02-24 11:43 68K 
[ ]Hemlibra-Vodic-za-zdravstvene-radnike-v.2.pdf2023-02-23 14:44 69K 
[IMG]7.-lista-ljekova-pod-dodatnim-pracenjem-slika-portal-1024x683.jpg2023-02-03 10:38 69K 
[IMG]Slika-1-1024x855.jpg2023-02-04 14:28 70K 
[IMG]1.-opste-informacije-slika-portal-300x181.png2023-02-03 10:37 71K 
[IMG]6.-lista-ozbiljnih-nezeljenih-dejstava-slika-portal.jpg2023-02-03 10:38 72K 
[IMG]7.-lista-ljekova-pod-dodatnim-pracenjem-slika-portal.jpg2023-02-03 10:38 73K 
[IMG]Slika-3-768x979.jpg2023-02-04 14:28 74K 
[IMG]4.-pisma-zdravstvenim-radnicima-slika-portal-300x176.png2023-02-03 10:37 75K 
[IMG]8.-godisnji-izvjestaji-slika-portal-300x147.png2023-02-03 10:38 77K 
[IMG]5.-mjere-minimizacije-rizika-slika-portal-300x143.png2023-02-03 10:37 78K 
[IMG]1.opste-informacije-finalna-slika-300x170.png2023-02-08 12:16 79K 
[IMG]Slika-3-804x1024.jpg2023-02-04 14:28 79K 
[IMG]6.-lista-ozbiljnih-nezeljenih-dejstava-finalna-slika-300x153.png2023-02-08 12:16 83K 
[IMG]3.-uputstva-za-nosioca-dozvole-za-lijek-slika-portal-1024x678.jpg2023-02-03 10:37 85K 
[ ]CellCept-Upitnik-za-zdravstvene-radnike-v.1.pdf2023-02-17 09:52 95K 
[ ]Oznaka-za-edukativne-materijale.pdf2023-02-06 11:17 95K 
[ ]Humira-Kartica-za-pedijatrijske-pacijente-v.3.pdf2023-02-23 14:47 96K 
[ ]Humira-Kartica-za-odrasle-pacijente-v.3.pdf2023-02-23 14:47 97K 
[ ]Izvjestaj-17022023.pdf2023-02-20 08:49 98K 
[ ]Instruction-on-the-manner-of-submitting-periodic-safety-update-report.pdf2023-02-03 12:15 101K 
[ ]CellCept-Upitnik-za-pacijente-v.1.pdf2023-02-17 09:49 103K 
[IMG]humani-ljekovi-768x186.png2023-02-24 12:16 103K 
[IMG]3.-uputstva-za-nosioca-dozvole-za-lijek-slika-portal.jpg2023-02-03 10:37 105K 
[ ]Contents-of-the-Investigators-Brochure.pdf2023-02-24 11:54 116K 
[ ]Fees_medical-devices_CALIMS_2009.pdf2023-02-10 07:26 117K 
[ ]Dnevni-red_Komisija_17.05.2022.pdf2023-02-21 08:44 118K 
[ ]CellCept-Vodic-za-zdravstvene-radnike-v.1.pdf2023-02-17 09:52 118K 
[IMG]Slika-2-1536x881.jpg2023-02-04 14:28 119K 
[ ]Dnevni-red_Komisija_28.02.2022.pdf2023-02-21 08:46 120K 
[ ]Dnevni-red-r_Komisija_29.09.2022.pdf2023-02-21 08:36 120K 
[ ]Dnevni-red_o_Komisija_24.02.2023.pdf2023-02-27 13:27 121K 
[ ]2021_12_27_Zapisnik_r_Komisija_2021_12_27_.pdf2023-02-21 09:02 124K 
[ ]2022.8.25_Zapisnik_o_Komisija_25.08.2022.pdf2023-02-21 12:11 124K 
[ ]29_07_2022_Zapisnik_o_Komisija_29_07_2022-1.pdf2023-02-21 09:37 125K 
[ ]29_07_2022_Zapisnik_o_Komisija_29_07_2022.pdf2023-02-21 08:57 125K 
[ ]23_06_2022_Zapisnik_o_Komisija_23_06_2022.pdf2023-02-21 09:00 125K 
[ ]28_02_2022_Zapisnik_r_Komisija_28_02_2022.pdf2023-02-21 09:02 126K 
[ ]31_10_2022_Zapisnik_r_Komisija_31_10_2022.pdf2023-02-21 08:52 126K 
[ ]17_05_2022_Zapisnik_r_o_Komisija_17_05_2022.pdf2023-02-21 09:01 127K 
[ ]25_08_2022_Zapisnik_r_Komisija_25_08_2022-1.pdf2023-02-21 09:36 127K 
[ ]25_08_2022_Zapisnik_r_Komisija_25_08_2022.pdf2023-02-21 08:53 127K 
[ ]2022.11.15_Zapisnik_r_Komisija_15.11.2022.pdf2023-02-21 13:35 127K 
[ ]2022.12.21_Zapisnik_r_Komisija_21.12.2022.pdf2023-02-21 13:36 128K 
[ ]2022.7.29_Zapisnik_r_Komisija_29.07.2022.pdf2023-02-21 10:54 130K 
[ ]29_09_2022_Zapisnik_r_Komisija_29_09_2022.pdf2023-02-21 08:53 130K 
[ ]Darzalex-Kartica-za-pacijente.pdf2023-02-23 10:30 131K 
[ ]30_03_2022_Zapisinik_r_Komisija_30_03_2022.pdf2023-02-21 09:01 131K 
[ ]Instruction-for-applicants-for-obtaining-amending-cessation-of-validity-of-wholesale-authorisation-for-medicines.pdf2023-02-06 11:48 131K 
[ ]30_06_2022_Zapisnik_r_Komisija_30_06_2022.pdf2023-02-21 09:00 132K 
[ ]2022.11.18_Zapisnik_o_Komisija_18.11.2022.pdf2023-02-21 13:35 132K 
[ ]2021_11_19_Zapisnik_r_Komisija_2021_11_19.pdf2023-02-21 09:03 133K 
[IMG]4.-pisma-zdravstvenim-radnicima-finalna-slika-768x341.png2023-02-08 12:16 135K 
[ ]Instruction-for-applicants-for-obtaining-amending-extension-cessation-of-validity-of-wholesale-authorisation-for-narcotic-drugs.pdf2023-02-06 11:50 139K 
[ ]Documentation-required-for-approval-of-a-Clinical-Trial.pdf2023-02-24 11:49 142K 
[ ]Contents-of-a-Clinical-Trial-Protocol.pdf2023-02-24 11:53 145K 
[ ]Alunbrig-Kartica-za-pacijenta-v.1.pdf2023-02-16 14:13 151K 
[ ]Enbrel-Kartica-za-pacijenta.pdf2023-02-23 13:00 158K 
[ ]Ovlascenje-za-preuzimanje-pristupnih-parametara.pdf2023-02-15 12:29 164K 
[ ]CellCept-Obrazac-za-prijavu-i-pracenje-trudnoce-za-zdravstvene-radnike-v.1.pdf2023-02-17 09:52 165K 
[ ]Iberogast-DHPC.pdf2023-02-24 12:08 166K 
[ ]Manner-of-submitting-application-and-documentation-for-obtaining-MA-hum-1.pdf2023-02-07 14:37 168K 
[ ]Manner-of-submitting-application-and-documentation-for-obtaining-MA-hum-2.pdf2023-02-07 14:44 168K 
[ ]Manner-of-submitting-application-and-documentation-for-obtaining-MA-hum.pdf2023-02-07 14:36 168K 
[ ]Zahtjev-za-izdavanje-pristupnih-parametara.pdf2023-02-15 12:29 170K 
[ ]Contents-of-the-Clinical-Study-Report.pdf2023-02-24 11:56 173K 
[ ]CellCept-Vodic-za-pacijente-v.1.pdf2023-02-17 09:49 173K 
[ ]Documentationrequiredforissuanceauthorisationforimportexportandtransitofprecursorsandmedicinescontainingprecursorsandinstructionforcompletingtheapplicationform.pdf2023-02-14 14:26 183K 
[ ]Keytruda-Kartica-za-pacijenta-v.2.pdf2023-02-23 14:51 183K 
[ ]Fees_medicines_CALIMS-2013-1.pdf2023-02-10 07:21 184K 
[ ]Fees_medicines_CALIMS-2013-2.pdf2023-02-10 07:21 184K 
[ ]Fees_medicines_CALIMS-2013.pdf2023-02-10 07:17 184K 
[ ]Documentationrequiredforissuanceauthorisationforimportexportandtransitofdrugs_narcoticdrugs_psychotropicsubstances_andinstructionforcompletingtheapplicationform.pdf2023-02-14 14:25 185K 
[IMG]humani-ljekovi-1024x249.png2023-02-24 12:16 185K 
[ ]Oznaka-za-pismo-zdravstvenim-radnicima.pdf2023-02-06 10:29 199K 
[ ]Rulebook_on_pharmacovigilance_oct-2014.pdf2023-02-03 12:10 199K 
[ ]Potrebna-dokumentacija-za-izdavanje-odobrenja-za-uvoz-medicinskih-sredstava-koja-nijesu-registrovana.pdf2023-02-08 14:12 201K 
[ ]Manner-of-submitting-application-and-documentation-for-the-renewal-of-marketing-authorisation-for-medicines-for-human-use-1.pdf2023-02-07 14:48 202K 
[ ]Manner-of-submitting-application-and-documentation-for-the-renewal-of-marketing-authorisation-for-medicines-for-human-use.pdf2023-02-07 09:59 202K 
[ ]Dnevni-red_Komisija_30_03_2022.pdf2023-02-21 08:45 204K 
[ ]Instruction-for-applicants-for-obtaining-amending-extension-cessation-of-validity-of-the-wholesale-authorisation-for-veterinary-narcotic-drugs_sep-181.pdf2023-02-06 11:55 208K 
[ ]Dnevni-red_Komisija-r_31.10.2022.pdf2023-02-21 08:35 208K 
[ ]Hemlibra-Kartica-za-pacijenta-v.2.pdf2023-02-23 14:45 208K 
[ ]Dnevni-red_Komisija-o_29.07.2022.pdf2023-02-21 08:41 208K 
[ ]Dnevni-red_r_Komisija_15_11_2022.pdf2023-02-21 08:33 208K 
[ ]Dnevni-red_Komisija-o_25.08.2022.pdf2023-02-21 08:36 208K 
[ ]Dnevni-red_Komisija-r_25.08.2022.pdf2023-02-21 08:40 209K 
[ ]Dnevni-red_Komisija_23.06.2022.pdf2023-02-21 08:43 211K 
[ ]Dnevni-red_Komisija-r_29.07.2022_2.pdf2023-02-21 08:41 212K 
[ ]Dnevni-red_Komisija_30.06.2022.pdf2023-02-21 08:42 213K 
[ ]Dnevni-red_o_Komisija_18_11_2022.pdf2023-02-21 08:31 215K 
[ ]Diane-35-Kartica-za-pacijentkinje-v.1.pdf2023-02-23 10:32 221K 
[ ]Diane-35-Kontrolna-lista-za-propisivace-v.1.pdf2023-02-23 10:31 229K 
[ ]Lemtrada-Kontrolna-lista-za-ljekare-v.3.pdf2023-02-23 14:55 236K 
[IMG]3.uputstva-za-nosioca-dozvole-za-lijek-finalna-slika-768x400.png2023-02-08 12:16 236K 
[ ]Keytruda-Brosura-za-pacijenta-v.2.pdf2023-02-23 14:51 236K 
[ ]Nacin-podnosenja-zahtjeva-i-dokumentacije-za-formiranje_uskladivanje-maksimalne-cijene-lijeka_21022023.pdf2023-02-21 23:01 237K 
[ ]Required-documentation-for-import-of-veterinary-medicines-that-do-not-have-marketing-authorisation.pdf2023-02-08 11:14 261K 
[ ]Rulebook_on_Clinial_trials.pdf2023-02-24 11:35 288K 
[ ]Exjade-Kontrolna-lista-za-ljekare-v.1.pdf2023-02-23 13:16 291K 
[ ]Kadcyla-Vodic-za-zdravstvene-radnike-v.4.pdf2023-02-23 14:49 295K 
[ ]Eftil-Kartica-za-pacijentkinje-v.3.pdf2023-02-23 12:52 299K 
[ ]Manner-of-submitting-application-and-documentation-for-obtaining-marketing-authorisation-for-veterinary-medicines.pdf2023-02-14 13:57 303K 
[ ]REQUIRED-DOCUMENTATION-FOR-ISSUANCE-OF-EXPERT-OPINION-ON-CLASSIFICATION-OF-MEDICAL-DEVICES.pdf2023-02-10 13:19 308K 
[ ]Manner-of-submitting-application-and-documentation-for-obtaining-marketing-authorisation-for-veterinary-medicines-1.pdf2023-02-23 08:34 320K 
[ ]Manner-of-submission-of-application-and-documentation-for-the-transfer-of-marketing-authorisation-to-the-other-marketing-authorisation-holder.pdf2023-02-23 08:34 323K 
[ ]Documentation-required-for-issuance-of-import-authorisation-for-medical-devices-that-are-not-registered-00000002.pdf2023-02-10 13:25 324K 
[ ]Erivedge-Vodic-za-pacijente-v.4.pdf2023-02-23 13:05 330K 
[ ]Cesta-pitanja-eng.pdf2023-02-10 13:29 333K 
[ ]Gilenya-Kontrolna-lista-za-ljekare-v.4.pdf2023-02-23 14:39 344K 
[ ]Eliquis-Vodic-za-propisivace.pdf2023-02-23 12:59 347K 
[ ]Esbriet-Kontrolna-lista-za-propisivace-v.4.pdf2023-02-23 13:07 355K 
[ ]Instruction-for-completing-excel-table-for-import-of-veterinary-medicinal-products-that-do-not-have-marketing-authorisation_31_03.pdf2023-02-08 11:15 364K 
[IMG]5.-mjere-minimizacije-rizika-slika-portal-768x366.png2023-02-03 10:37 372K 
[IMG]humani-ljekovi-1536x373.png2023-02-24 12:16 376K 
[ ]Uputstvo-o-nacinu-dostavljanja-pisma-zdravstvenim-radnicima.pdf2023-02-06 10:31 378K 
[ ]Manner-of-submission-of-application-and-documentation-for-the-transfer-of-marketing-authorisation-to-the-other-marketing-authorisation-holder_17_10_2022-1.pdf2023-02-07 14:46 384K 
[ ]Manner-of-submission-of-application-and-documentation-for-the-transfer-of-marketing-authorisation-to-the-other-marketing-authorisation-holder_17_10_2022-2.pdf2023-02-14 14:12 384K 
[ ]Manner-of-submission-of-application-and-documentation-for-the-transfer-of-marketing-authorisation-to-the-other-marketing-authorisation-holder_17_10_2022.pdf2023-02-07 10:02 384K 
[ ]Bortezomib-Pliva-Poster-sa-uputstvima-za-pripremu-lijeka-v.2.pdf2023-02-17 07:33 392K 
[ ]Erivedge-Podsjetnik-za-zdravstvene-radnike-v.4.pdf2023-02-23 13:04 397K 
[IMG]6.-lista-ozbiljnih-nezeljenih-dejstava-finalna-slika-768x391.png2023-02-08 12:16 405K 
[ ]Nacin-podnosenja-zahtjeva-i-potrebna-dokumentacija-za-izdavanje-dozvole-za-stavljanje-veterinarskog-lijeka-u-promet.pdf2023-02-22 23:10 408K 
[ ]Uputstvo-o-nacinu-dostavljanja-pisma-zdravstvenim-radnicima-1.pdf2023-02-06 11:19 408K 
[IMG]4.-pisma-zdravstvenim-radnicima-slika-portal-768x452.png2023-02-03 10:37 410K 
[IMG]1.-opste-informacije-slika-portal-768x463.png2023-02-03 10:37 418K 
[IMG]3.uputstva-za-nosioca-dozvole-za-lijek-finalna-slika.png2023-02-08 12:16 420K 
[IMG]Slika-1.jpg2023-02-04 14:28 421K 
[IMG]8.-godisnji-izvjestaji-slika-portal-768x376.png2023-02-03 10:38 427K 
[IMG]1.opste-informacije-finalna-slika-768x435.png2023-02-08 12:16 455K 
[ ]Erivedge-Smjernice-za-savjetovanje-pacijenata-v.4.pdf2023-02-23 13:04 458K 
[ ]2-Nacin-podnosenja-zahtjeva-i-potrebna-dokumentacija-za-izdavanje-dozvole-za-lijek-za-upotrebu-u-veterinarstvu.pdf2023-02-20 12:31 469K 
[ ]Statut-Instituta-za-ljekove-i-medicinska-sredstva.pdf2023-02-24 07:33 487K 
[ ]3-Nacin-podnosenja-zahtjeva-i-dokumentacije-za-prenos-dozvole-za-lijek-na-drugog-nosioca-dozvole-za-lijek.pdf2023-02-20 12:46 490K 
[ ]Dnevni-red_Komisija_27_12_2021.pdf2023-02-21 08:47 527K 
[IMG]humani-ljekovi.png2023-02-24 12:16 558K 
[ ]Eftil-Godisnji-obrazac-v.3.pdf2023-02-23 12:49 559K 
[ ]Eftil-Poster-podsjetnik-za-farmaceute-v.3.pdf2023-02-23 12:49 569K 
[IMG]8.-godisnji-izvjestaji-slika-portal.png2023-02-03 10:38 572K 
[ ]Ezinelle-Informacije-za-pacijentkinje-v.2.pdf2023-02-23 13:23 580K 
[ ]DECISION-ON-THE-PAYMENT-METHOD-AND-AMOUNT-OF-FEES.pdf2023-02-10 08:23 595K 
[ ]Arava-Brosura-za-pacijente-v.2.pdf2023-02-16 14:15 597K 
[IMG]5.-mjere-minimizacije-rizika-slika-portal-1024x488.png2023-02-03 10:37 612K 
[ ]Gilenya-Kartica-za-pacijentkinje-sa-podsjetnikom-o-trudnoci-v.1.pdf2023-02-23 14:41 622K 
[ ]vol_9b_2011-10_0.pdf2023-02-08 12:27 644K 
[IMG]5.-mjere-minimizacije-rizika-slika-portal.png2023-02-03 10:37 647K 
[IMG]6.-lista-ozbiljnih-nezeljenih-dejstava-finalna-slika-1024x522.png2023-02-08 12:16 656K 
[IMG]1.-opste-informacije-slika-portal-1024x617.png2023-02-03 10:37 700K 
[ ]Ezinelle-Uputstvo-za-farmaceute-v.3.pdf2023-02-23 13:23 707K 
[IMG]4.-pisma-zdravstvenim-radnicima-slika-portal.png2023-02-03 10:37 736K 
[ ]Arava-Brosura-za-ljekare-v.2.pdf2023-02-16 14:15 742K 
[ ]Ezinelle-Upitnik-za-pacijentkinje-v.1.pdf2023-02-23 13:23 747K 
[VID]Potpisivanje-Sporazuma.mp42023-02-04 14:28 754K 
[IMG]1.opste-informacije-finalna-slika-1024x580.png2023-02-08 12:16 763K 
[IMG]Slika-3.jpg2023-02-04 14:28 796K 
[ ]Rulebook_on_more-detailed-conditions-for-issuance-of-marketing-authorisation-for-a-medicine-2016_2019.pdf2023-02-07 09:12 831K 
[ ]Gilenya-Vodic-za-roditelje-staratelje-v.1.pdf2023-02-23 14:41 850K 
[ ]Aubagio-Kartica-za-pacijenta-v.2.pdf2023-02-16 14:20 867K 
[ ]Gilenya-Kartica-podsjetnik-za-pacijenta-v4.pdf2023-02-23 14:41 875K 
[IMG]6.-lista-ozbiljnih-nezeljenih-dejstava-finalna-slika.png2023-02-08 12:16 919K 
[IMG]1.-opste-informacije-slika-portal.png2023-02-03 10:37 950K 
[ ]Dnevni-red_Komisija_19.11.2021.pdf2023-02-21 08:47 1.0M 
[ ]Exelon-Dnevnik-za-pacijenta-v.3.pdf2023-02-23 13:08 1.0M 
[ ]Aubagio-Vodic-za-propisivace-v.2.pdf2023-02-16 14:20 1.1M 
[ ]Eftil-Vodic-za-pacijentkinje-v.3.pdf2023-02-23 12:52 1.1M 
[IMG]1.opste-informacije-finalna-slika.png2023-02-08 12:16 1.2M 
[ ]Pravilnik-o-tajnosti-podataka-i-poslovnoj-tajni-00000002.pdf2023-02-01 07:20 1.2M 
[ ]CInMED-communication-action-plan-00000003.pdf2023-02-07 09:04 1.3M 
[ ]Development-Strategy-of-the-Institute-2022-20026-00000003.pdf2023-02-07 09:04 1.4M 
[ ]Eylea-Vodic-za-pacijenta-v.3.pdf2023-02-23 13:19 1.4M 
[ ]Bortezomib-Pliva-Kartica-sa-uputstvima-za-doziranje.pdf2023-02-17 07:33 1.4M 
[IMG]Slika-2.jpg2023-02-04 14:28 1.4M 
[ ]Eylea-Vodic-za-ljekare-v.3.pdf2023-02-23 13:18 1.4M 
[ ]Entyvio-Kartica-za-pacijenta-v.3.pdf2023-02-23 13:02 1.6M 
[ ]Exjade-Vodic-za-zdravstvene-radnike-v.2.pdf2023-02-23 13:16 1.6M 
[ ]Eftil-Vodic-za-zdravstvene-radnike-v.3.pdf2023-02-23 12:49 1.8M 
[VID]Izjava-doc.-dr-med.-spec.-Sneane-Mugoie.mp42023-02-04 14:28 2.6M 
[ ]Fingolimod-Pharmascience-Vodic-za-pacijente-v.5.pdf2023-02-23 14:34 2.8M 
[ ]Fingolimod-Pharmascience-Kartica-za-pacijentkinje-sa-podsjetnikom-o-trudnoci-v.1.pdf2023-02-23 14:34 3.0M 
[ ]Fingolimod-Pharmascience-Vodic-za-roditelje-staratelje-v.3.pdf2023-02-23 14:34 3.2M 
[ ]Exjade-Vodic-za-pacijente-v.2.pdf2023-02-23 13:17 3.3M 
[ ]Entyvio-Vodic-za-propisivace-v.3-1.pdf2023-02-23 13:01 3.4M 
[ ]Entyvio-Vodic-za-propisivace-v.3.pdf2023-02-16 10:04 3.4M 
[ ]Darzalex-Razumijevanje-i-ublazavanje-interferencije-daratumumaba-v.1.pdf2023-02-23 10:27 3.6M 
[ ]Fingolimod-Pharmascience-Kontrolna-lista-za-propisivace-v.5.pdf2023-02-23 14:33 3.7M 
[ ]Darzalex-Brosura-za-zdravstvene-radnike-v.1.pdf2023-02-23 10:26 3.8M 
[ ]Cerezyme-Prirucnik-za-pacijente-koji-primaju-infuzijsku-terapiju-lijeka-u-kucnim-uslovima-v.3.pdf2023-02-17 09:55 4.0M 
[ ]Cerezyme-Uputstvo-za-rekonstituciju-lijeka-za-pacijente-v.3.pdf2023-02-17 10:05 4.0M 
[VID]YouCut_20230204_132325502.mp42023-02-04 14:29 4.6M 
[ ]Cerezyme-Prirucnik-za-zdravstvene-radnike-za-infuziju-lijeka-u-kucnim-uslovima-v.3.pdf2023-02-17 10:12 5.2M 
[ ]Sjednica-Upravnog-odbora-od-27.12.2022.-godine.pdf2023-02-22 10:43 5.5M 
[ ]Cerezyme-Uputstvo-za-rekonstituciju-lijeka-za-zdravstvene-radnike-v.3.pdf2023-02-17 10:17 6.2M 
Apache/2.4.52 (Ubuntu) Server at cinmed.me Port 443